Lifestyle Intervention Using Mobile Technology in Patients With High Cardiovascular Risk

NACompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

March 1, 2020

Study Completion Date

March 1, 2020

Conditions
Primary PreventionDigital HealthLifestyle Risk Reduction
Interventions
BEHAVIORAL

Intervention using mobile technology

Each study patients that are randomized to IMT plus usual care group will receive a group of smart devices including mobile phone (Vestel Venus e2) (Vestel, Manisa, Turkey), wristband (Xiaomi band 2) (Beijing Xiaomi Technology Co., Beijing, China), weight scale (Bluecat, Yongkang Tiansheng Electronic Co., Zhejiang, China) and blood pressure monitor (Clever Chek TD-3250) (TaiDoc Technology Co., Taipei County, Taiwan)

Trial Locations (1)

34668

Dr. Siyami Ersek thoracic and cardiovascular surgery research and training hospital, Istanbul

All Listed Sponsors
collaborator

Turk Telekomunikasyon A.Ş., Istanbul, Turkey

UNKNOWN

lead

Ministry of Health, Turkey

OTHER_GOV

NCT03397849 - Lifestyle Intervention Using Mobile Technology in Patients With High Cardiovascular Risk | Biotech Hunter | Biotech Hunter